Vimarsana
Biggest News Aggregation in the World

Page 8 - Eceptor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eceptor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eceptor Today - Breaking & Trending Today

Study uncovers the anti-aging role of vitamin D and vitamin D receptor in Drosophila midgut model - Vimarsana News

Study uncovers the anti-aging role of vitamin D and vitamin D receptor in Drosophila midgut model

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 16, Issue 3, entitled, "The anti-aging effect of vitamin D and vitamin D receptor in Drosophila midgut."

Novel approach uses patient's cells as "trojan horse" to target lung cancer cells - Vimarsana News

Novel approach uses patient's cells as "trojan horse" to target lung cancer cells

Lung cancer is not the most common form of cancer, but it is by far the deadliest.

New study defines clinical phenotype of Post-infectious ME/CFS, highlighting unique biomarker insights - Vimarsana News

New study defines clinical phenotype of Post-infectious ME/CFS, highlighting unique biomarker insights

The pathophysiological mechanisms of PI myalgic encephalitis/chronic fatigue syndrome (ME/CFS).

New immunotherapy target activin receptor 1C shows promise against cancer - Vimarsana News

New immunotherapy target activin receptor 1C shows promise against cancer

Drugs that target a receptor on immune cells called activin receptor 1C may combat tumor-induced immune suppression and help patients' immune systems fight back against cancer, according to a study by investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.

Natural killer cells lead the charge in cancer treatment innovation - Vimarsana News

Natural killer cells lead the charge in cancer treatment innovation

Review synthesizes research on NK cells' role in cancer immunity and their potential in therapeutics through bioengineering, immune checkpoint inhibitors, and cell engagers, highlighting ongoing preclinical and clinical trials.